366780-93-0Relevant articles and documents
TG2 INHIBITOR COMPOUNDS AND USES THEREOF
-
Paragraph 00407; 00408; 00409, (2017/11/16)
There are provided Tissue Transglutaminase (TG2) inhibitor compounds, and compositions and methods of use thereof for the prevention or treatment of a cancer. Compounds of Formula I, and pharmaceutically acceptable salts thereof, are provided: Formula (I).
Synthesis of dipeptide-bound epoxides and α,β-unsaturated amides as potential irreversible transglutaminase inhibitors
De Macedo, Pierre,Marrano, Claudio,Keillor, Jeffrey W
, p. 355 - 360 (2007/10/03)
Herein we report the synthesis of 24 novel peptides as potential irreversible inactivators of transglutaminase (TGase). These peptides were designed to resemble Cbz-L-Gly, known to be a good TGase substrate, and to include either α,β-unsaturated amide groups or the corresponding epoxide groups. The side chain length of the amino acid residue bearing the inhibitor group was also varied in order to permit investigation of this effect. Copyright